C. Onursal Et Al. , "Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts," Journal of Diabetes and its Complications , vol.37, no.4, 2023
Onursal, C. Et Al. 2023. Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts. Journal of Diabetes and its Complications , vol.37, no.4 .
Onursal, C., Reel, B., Bintepe, C., Guzeloglu, M., Ersoy, N., & BAĞRIYANIK, H. A., (2023). Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts. Journal of Diabetes and its Complications , vol.37, no.4.
Onursal, Ceylan Et Al. "Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts," Journal of Diabetes and its Complications , vol.37, no.4, 2023
Onursal, Ceylan Et Al. "Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts." Journal of Diabetes and its Complications , vol.37, no.4, 2023
Onursal, C. Et Al. (2023) . "Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts." Journal of Diabetes and its Complications , vol.37, no.4.
@article{article, author={Ceylan Onursal Et Al. }, title={Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts}, journal={Journal of Diabetes and its Complications}, year=2023}